about
Hormone replacement therapy to maintain cognitive function in women with dementiaHormone replacement therapy for cognitive function in postmenopausal womenWomen's perceptions of hormone replacement therapy: risks and benefits (1980-2002). A literature review.Hormone therapy and cardiovascular disease: a systematic review and meta-analysis.Relationship between higher estradiol levels and 9-year mortality in older women: the Invecchiare in Chianti studyPhyto-oestrogens: a potential role in the prevention of CHD?Why do women doctors in the UK take hormone replacement therapy?History of hot flashes and aortic calcification among postmenopausal womenPostmenopausal hormone therapy, SERMs, and coronary heart disease in women.Cognitive benefits of hormone therapy: cardiovascular factors and healthy-user bias.Healthy aging. A women's issue.Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in womenMortality associated with hormone replacement therapy in younger and older women: a meta-analysis.The medicalization of menopause: critique and consequences.A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects.Cardioprotective benefits of hormone replacement therapy.Hormones and heart disease: what we thought, what we have learned, what we still need to knowIssues of hormone replacement therapy and cardiovascular disease for elderly women.Postmenopausal estrogen therapy and depressive symptoms in older women.Healthy user and related biases in observational studies of preventive interventions: a primer for physicians.A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo Study.Postmenopausal hormone replacement therapy.Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives.Hormone replacement therapy and cardioprotection: the end of the tale?Clinical pharmacology of anti-Alzheimer drugs.Estrogen and Cardiovascular Disease: Is Timing Everything?Low use of long-term hormone replacement therapy in DenmarkHormone replacement therapy for all? Not for everybody.Mortality following development of breast cancer while using oestrogen or oestrogen plus progestin: a computer record-linkage study.Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies.Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older womenThe effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women.Factors contributing to skeletal health of postmenopausal Mexican-American women.Sex hormones and the cardiovascular system: effects on arterial function in women.Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?Treatment of vasomotor symptoms in the menopausal transition and postmenopausally: psychiatric comorbidity.Familial Alzheimer disease in Latinos: interaction between APOE, stroke, and estrogen replacement.The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.Progress in osteoporosis and fracture prevention: focus on postmenopausal women.Overweight and effect of hormone replacement therapy on lipid profiles in postmenopausal women.
P2860
Q24241789-BD201759-35FD-4BDA-9CA3-67A94965374EQ24242542-F8A72442-920D-4EAA-93B7-00A1ED94BE6AQ33213520-425AFC70-3F78-4F9C-9E13-8B40B2C92942Q33231108-735F5180-45B9-402B-844A-B64D1F40CDFAQ33557595-0B6C75A6-D006-4F0A-BDB1-5D5E986EE041Q33644539-B642C368-F89A-4417-A512-EC6D0DAA579BQ33704462-C496EF64-5821-4F7E-9D38-6D74FE92D208Q33721739-75033DD7-CB64-4BD5-A1B0-D4EB1D5C76D3Q33757741-85720631-134B-41BB-AFCA-A2D2E12E0FFEQ33761005-CCB574A5-3D81-4111-9AFB-A909BCC8D685Q34186876-FAE13148-F999-49B1-9327-3F4ABAF315D4Q34272961-7FAF7794-2D22-4CBA-B52C-3BEDDC14BC6CQ34328229-318FA69D-6261-4472-A5C1-189DE368334EQ34504839-9BE7B86F-DF31-48E5-AE18-08E2B2C60EF6Q34573282-B6EAC807-3C17-4ABD-905C-6DA5F59A8772Q34585847-90233AD2-939D-49CE-941C-7621AC1F518AQ34675309-8E4FF1BD-CC49-44DA-B199-BD6B1F0D0DBAQ34714748-6BC6B4D7-4927-4A37-A5FD-AEC85D2C6D82Q34746437-98614D1F-67D2-4E02-BD5E-FDC8550F2763Q34799001-7BE9729A-D070-4A56-8228-7E0C2739DACFQ35068814-F7E80F93-9DD3-4BE4-8F2E-95924572AC8CQ35245034-B105D625-F9FE-41A3-AD81-A3ACF6C47B47Q35419972-5442937E-FD8F-4645-9683-DB6C4ABEFF26Q35596294-6B2B3ACD-3346-455E-8093-00224A0508AEQ35688610-F3B472B3-7F83-46A5-AEB9-7B97982405BEQ35812293-4468A8CE-73C8-49C6-91E7-4551829BBD67Q36053335-FB2F868E-CC7F-4634-A736-285865F6C315Q36599670-C2CDF8FD-1F02-466E-A482-D2A079AA377BQ36615213-554946EC-28AC-490C-87E0-C4C5DE9D4819Q36631882-96313DA6-F381-4ACC-AE29-7472DC5B6793Q36645889-548034C2-9A6B-4B95-B659-8C982E7D6FB8Q36673647-C10DC94A-1365-44C7-BBFF-08B148EDD4B3Q36793658-0D9D67FF-1ABA-4476-86E3-7BA904B5D6C2Q36854152-12367E4A-36A3-47A0-84D3-882CDE8D8818Q36885553-AFC0884A-FFCB-4D90-B932-CA9A6FE15852Q37014593-82D16A46-3567-4D7C-AFA8-D00D8C075BC6Q37090625-0E419B96-6EB5-4C3B-B750-71B4CA34BAE0Q37385026-A932196F-5FC6-40AE-8868-BA30975EDE6FQ37453973-FB80B061-BE53-4D1D-A96C-7EB683F85D2DQ37477171-73E2C0BE-EF28-41A4-8C7D-E24C06DB3699
P2860
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Postmenopausal estrogen and prevention bias.
@en
Postmenopausal estrogen and prevention bias.
@nl
type
label
Postmenopausal estrogen and prevention bias.
@en
Postmenopausal estrogen and prevention bias.
@nl
prefLabel
Postmenopausal estrogen and prevention bias.
@en
Postmenopausal estrogen and prevention bias.
@nl
P1476
Postmenopausal estrogen and prevention bias.
@en
P304
P356
10.7326/0003-4819-115-6-455
P407
P577
1991-09-01T00:00:00Z